| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Molecular Medicine, Wadsworth Center, New York State Department of Health, Albany, New York 12201–0509
Tumor cells are characterized by uncontrolled growth, invasion to surrounding tissues, and metastatic spread to distant sites. Mortality from cancer is often due to metastasis since surgical removal of tumors can enhance and prolong survival. The integrins constitute a family of transmembrane receptor proteins composed of heterodimeric complexes of noncovalently linked 
and ß chains. Integrins function in cell-to-cell and cell-to-extracellular matrix (ECM) adhesive interactions and transduce signals from the ECM to the cell interior and vice versa. Hence, the integrins mediate the ECM influence on cell growth and differentiation. Since these properties implicate integrin involvement in cell migration, invasion, intra- and extra-vasation, and platelet interaction, a role for integrins in tumor growth and metastasis is obvious. These findings are underpinned by observations that the integrins are linked to the actin cytoskeleton involving talin, vinculin, and -actinin as intermediaries. Such cytoskeletal changes can be manifested by rounded cell morphology, which is often coincident with tumor transformation via decreased or increased integrin expression patterns. For the various types of cancers, different changes in integrin expression are further associated with tumor growth and metastasis. Tumor progression leading to metastasis appears to involve equipping cancer cells with the appropriate adhesive (integrin) phenotype for interaction with the ECM. Therapies directed at influencing integrin cell expression and function are presently being explored for inhibition of tumor growth, metastasis, and angiogenesis. Such therapeutic strategies include anti-integrin monoclonal antibodies, peptidic inhibitors (cyclic and linear), calcium-binding protein antagonists, proline analogs, apoptosis promotors, and antisense oligonucleotides. Moreover, platelet aggregation induced by tumor cells, which facilitates metastatic spread, can be inhibited by the disintegrins, a family of viper venom–like peptides. Therefore, adhesion molecules from the integrin family and components of angiogenesis might be useful as tumor progression markers for prognostic and for diagnostic purposes. Development of integrin cell expression profiles for individual tumors may have further potential in identifying a cell surface signature for a specific tumor type and/or stage. Thus, recent advances in elucidating the structure, function, ECM binding, and signaling pathways of the integrins have led to new and exciting modalities for cancer therapeutics and diagnoses.
This article has been cited by other articles:
|
|
 |
|
  S. Huveneers, S. Arslan, B. van de Water, A. Sonnenberg, and E. H. J. Danen Integrins Uncouple Src-induced Morphological and Oncogenic Transformation J. Biol. Chem., May 9, 2008; 283(19): 13243 - 13251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Q. Zhu, S. N. Popova, E. R. S. Brown, D. Barsyte-Lovejoy, R. Navab, W. Shih, M. Li, M. Lu, I. Jurisica, L. Z. Penn, et al. Integrin {alpha}11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells PNAS, July 10, 2007; 104(28): 11754 - 11759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Otis, S. Campbell, M. D Payet, and N. Gallo-Payet Expression of extracellular matrix proteins and integrins in rat adrenal gland: importance for ACTH-associated functions J. Endocrinol., June 1, 2007; 193(3): 331 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1087 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Galliher and W. P. Schiemann Src Phosphorylates Tyr284 in TGF-{beta} Type II Receptor and Regulates TGF-{beta} Stimulation of p38 MAPK during Breast Cancer Cell Proliferation and Invasion Cancer Res., April 15, 2007; 67(8): 3752 - 3758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Miltyk, E. Karna, and J. A. Palka Prolidase-Independent Mechanism of Camptothecin-Induced Inhibition of Collagen Biosynthesis in Cultured Human Skin Fibroblasts J. Biochem., February 1, 2007; 141(2): 287 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Taglia, D. Matusiak, K. A. Matkowskyj, and R. V. Benya Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G182 - G190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J R Puddefoot, U K I Udeozo, S Barker, and G P Vinson The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion. Endocr. Relat. Cancer, September 1, 2006; 13(3): 895 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yan and R. Shao Transduction of a Mesenchyme-specific Gene Periostin into 293T Cells Induces Cell Invasive Activity through Epithelial-Mesenchymal Transformation J. Biol. Chem., July 14, 2006; 281(28): 19700 - 19708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Burvenich, S. Schoonooghe, B. Cornelissen, P. Blanckaert, E. Coene, C. Cuvelier, N. Mertens, and G. Slegers In vitro and In vivo Targeting Properties of Iodine-123- or Iodine-131-Labeled Monoclonal Antibody 14C5 in a Non-Small Cell Lung Cancer and Colon Carcinoma Model Clin. Cancer Res., October 15, 2005; 11(20): 7288 - 7296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Godefroy, A. Moreau-Aubry, E. Diez, B. Dreno, F. Jotereau, and Y. Guilloux {alpha}v{beta}3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen J. Exp. Med., July 5, 2005; 202(1): 61 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H.J. Danen, J. van Rheenen, W. Franken, S. Huveneers, P. Sonneveld, K. Jalink, and A. Sonnenberg Integrins control motile strategy through a Rho-cofilin pathway J. Cell Biol., May 9, 2005; 169(3): 515 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K S Nair, R Naidoo, and R Chetty Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value J. Clin. Pathol., April 1, 2005; 58(4): 343 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Baronas-Lowell, J. L. Lauer-Fields, J. A. Borgia, G. F. Sferrazza, M. Al-Ghoul, D. Minond, and G. B. Fields Differential Modulation of Human Melanoma Cell Metalloproteinase Expression by {alpha}2{beta}1 Integrin and CD44 Triple-helical Ligands Derived from Type IV Collagen J. Biol. Chem., October 15, 2004; 279(42): 43503 - 43513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Salicioni, A. Gaultier, C. Brownlee, M. K. Cheezum, and S. L. Gonias Low Density Lipoprotein Receptor-related Protein-1 Promotes {beta}1 Integrin Maturation and Transport to the Cell Surface J. Biol. Chem., March 12, 2004; 279(11): 10005 - 10012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Bojesen, A. Tybjaerg-Hansen, and B. G. Nordestgaard Integrin {beta}3 Leu33Pro Homozygosity and Risk of Cancer J Natl Cancer Inst, August 6, 2003; 95(15): 1150 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Vella, N. M. Thielens, B. Bersch, G. J. Arlaud, and P. Frachet A Recombinant Chimeric Epidermal Growth Factor-like Module with High Binding Affinity for Integrins J. Biol. Chem., May 23, 2003; 278(22): 19834 - 19843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Campbell, M. Otis, M. Cote, N. Gallo-Payet, and M. D. Payet Connection between Integrins and Cell Activation in Rat Adrenal Glomerulosa Cells: A Role for Arg-Gly-Asp Peptide in the Activation of the p42/p44mapk Pathway and Intracellular Calcium Endocrinology, April 1, 2003; 144(4): 1486 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gillan, D. Matei, D. A. Fishman, C. S. Gerbin, B. Y. Karlan, and D. D. Chang Periostin Secreted by Epithelial Ovarian Carcinoma Is a Ligand for {alpha}V{beta}3 and {alpha}V{beta}5 Integrins and Promotes Cell Motility Cancer Res., September 15, 2002; 62(18): 5358 - 5364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. H. de Groot, H. J. Broxterman, H. P. H. M. Adams, A. van Vliet, G. I. Tesser, Y. W. Elderkamp, A. J. Schraa, R. Jan Kok, G. Molema, H. M. Pinedo, et al. Design, Synthesis, and Biological Evaluation of a Dual Tumor-specific Motive Containing Integrin-targeted Plasmin-cleavable Doxorubicin Prodrug Mol. Cancer Ther., September 1, 2002; 1(11): 901 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Freyer, S. R. Johnson, and I. P. Hall Effects of Growth Factors and Extracellular Matrix on Survival of Human Airway Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 569 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Mizejewski Alpha-fetoprotein Structure and Function: Relevance to Isoforms, Epitopes, and Conformational Variants Experimental Biology and Medicine, May 1, 2001; 226(5): 377 - 408. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. M. Smorenburg and C. J. F. Van Noorden The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies Pharmacol. Rev., March 1, 2001; 53(1): 93 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tanaka, H. Kohno, M. Murakami, S. Kagami, and K. El-Bayoumy Suppressing Effects of Dietary Supplementation of the Organoselenium 1,4-Phenylenebis(methylene)selenocyanate and the Citrus Antioxidant Auraptene on Lung Metastasis of Melanoma Cells in Mice Cancer Res., July 1, 2000; 60(14): 3713 - 3716. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
